Pharmaceutical Commerce

Drug Pricing, PBM Reform, and the 2026 Midterms: What You Need to Know

PBM reform is accelerating via FTC settlements and CAA 2026, mandating data reporting, rebate pass-through in Part D, ...
High Times

Marijuana Reform Isn’t This White House’s Drug Policy Priority

Sara Carter, the former investigative journalist and Fox News contributor now serving as White House drug czar, has spent her early months emphasizing fentanyl, trafficking and addiction, not ...
Forbes

Regulatory Reform And AI Could Help Lower Drug Prices

WASHINGTON, DC - MAY 12: (L-R) National Institutes of Health (NIH) Director Jay Bhattacharya, Administrator for the Centers for Medicare & Medicaid Services (CMS) Mehmet Oz, U.S. President Donald ...
JD Supra

Bipartisan Drug Pricing Reform: The FPDP Act and Revival of Most-Favored-Nation Pricing

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump and bipartisan congressional leaders have introduced contemporaneous ...
Forbes

White House Says President Trump Has Made ‘No Final Decisions’ Around Marijuana Rescheduling

Weed Backer: if President Trump reclassifies cannabis as a Schedule III drug—on par with mild painkillers—it will be the biggest drug policy reform since 1970. According to The Post’s report on ...

Americans want big pharma reform. Candidates should deliver

Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why ...